Status:
COMPLETED
Promoting Informed Choice for Breast Cancer Screening
Lead Sponsor:
University of Colorado, Denver
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Breast Cancer
Eligibility:
FEMALE
39-49 years
Brief Summary
Identify the prevalence and predictors of reactance, self-exemption, disbelief, source derogation in reaction to evidence about mammography benefits and harms, and consequences for decision-making and...
Detailed Description
In this study, the goal is to identify the prevalence and predictors of reactance, self-exemption, disbelief, and source derogation in reaction to evidence about mammography benefits and harms, and co...
Eligibility Criteria
Inclusion
- Female
- Between 39-49 years of age
- No history of breast cancer
- No known BRCA 1/2 mutation
Exclusion
- Non-English or Spanish Speaking
- Persons unable to provide informed consent (e.g. sever dementia or cognitive disability or illiterate
- History of breast cancer
- Known BRCA 1/2 mutation
Key Trial Info
Start Date :
August 7 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 7 2023
Estimated Enrollment :
637 Patients enrolled
Trial Details
Trial ID
NCT05376241
Start Date
August 7 2020
End Date
May 7 2023
Last Update
October 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Colorado Anschutz Medical Campus
Aurora, Colorado, United States, 80045